Vgi Partners Pty LTD Increased Its Coca Cola Co (KO) Stake; Immunogen (IMGN) Shorts Raised By 7.56%

October 21, 2017 - By Michael Collier

Immunogen Incorporated (NASDAQ:IMGN) had an increase of 7.56% in short interest. IMGN’s SI was 19.88 million shares in October as released by FINRA. Its up 7.56% from 18.48M shares previously. With 4.16 million avg volume, 5 days are for Immunogen Incorporated (NASDAQ:IMGN)’s short sellers to cover IMGN’s short positions. The stock decreased 5.02% or $0.31 on October 20, reaching $5.86. About 3.26M shares traded. ImmunoGen, Inc. (NASDAQ:IMGN) has declined 3.49% since October 21, 2016 and is downtrending. It has underperformed by 20.19% the S&P500.

Vgi Partners Pty Ltd increased Coca Cola Co (KO) stake by 49.93% reported in 2017Q2 SEC filing. Vgi Partners Pty Ltd acquired 215,582 shares as Coca Cola Co (KO)’s stock rose 6.48%. The Vgi Partners Pty Ltd holds 647,315 shares with $29.03 million value, up from 431,733 last quarter. Coca Cola Co now has $197.82 billion valuation. The stock decreased 0.47% or $0.22 on October 20, reaching $46.38. About 9.65 million shares traded or 2.99% up from the average. The Coca-Cola Co (NYSE:KO) has declined 0.95% since October 21, 2016 and is downtrending. It has underperformed by 17.65% the S&P500.

Since May 3, 2017, it had 0 buys, and 4 selling transactions for $22.03 million activity. DOUGLAS J ALEXANDER JR sold $951,500 worth of The Coca-Cola Co (NYSE:KO) on Wednesday, May 3. Shares for $15.94M were sold by Finan Irial. $3.81 million worth of stock was sold by SMITH BRIAN JOHN on Wednesday, May 10. Perez Beatriz R also sold $1.32M worth of The Coca-Cola Co (NYSE:KO) on Wednesday, June 14.

Among 21 analysts covering Coca-Cola (NYSE:KO), 9 have Buy rating, 1 Sell and 11 Hold. Therefore 43% are positive. Coca-Cola had 57 analyst reports since July 21, 2015 according to SRatingsIntel. Bank of America maintained the stock with “Buy” rating in Monday, October 9 report. The rating was maintained by RBC Capital Markets on Friday, June 30 with “Buy”. BMO Capital Markets maintained the stock with “Market Perform” rating in Monday, July 31 report. As per Friday, August 7, the company rating was reinitiated by Barclays Capital. As per Tuesday, January 12, the company rating was upgraded by Stifel Nicolaus. The stock of The Coca-Cola Co (NYSE:KO) has “Buy” rating given on Thursday, April 21 by UBS. Sterne Agee CRT initiated the stock with “Buy” rating in Tuesday, July 21 report. The firm has “Market Perform” rating given on Wednesday, June 7 by BMO Capital Markets. Cowen & Co maintained it with “Hold” rating and $42.0 target in Tuesday, August 22 report. As per Thursday, April 21, the company rating was maintained by Citigroup.

Investors sentiment increased to 0.94 in 2017 Q2. Its up 0.15, from 0.79 in 2017Q1. It improved, as 49 investors sold KO shares while 618 reduced holdings. 123 funds opened positions while 504 raised stakes. 2.70 billion shares or 1.07% more from 2.67 billion shares in 2017Q1 were reported. Moreover, Dekabank Deutsche Girozentrale has 0.87% invested in The Coca-Cola Co (NYSE:KO). Sns Gru Limited owns 7,947 shares or 0.09% of their US portfolio. Meridian Mgmt Company holds 0.66% or 28,136 shares. Smith Asset Mngmt Grp Lp invested 0.62% in The Coca-Cola Co (NYSE:KO). Amica Pension Fund Board Of Trustees reported 139,933 shares stake. Apg Asset Nv stated it has 0.59% of its portfolio in The Coca-Cola Co (NYSE:KO). Penobscot Invest Mgmt Commerce Inc invested 0.35% in The Coca-Cola Co (NYSE:KO). Natixis holds 0.28% or 549,741 shares. The Arizona-based Autus Asset Limited has invested 0.15% in The Coca-Cola Co (NYSE:KO). Cambridge Advisors Incorporated invested in 0.15% or 8,137 shares. Buffington Mohr Mcneal holds 0.08% of its portfolio in The Coca-Cola Co (NYSE:KO) for 4,749 shares. Kemper Corporation Master Retirement holds 2.83% of its portfolio in The Coca-Cola Co (NYSE:KO) for 101,500 shares. Cedar Hill Assocs Ltd Liability Corp reported 0.05% of its portfolio in The Coca-Cola Co (NYSE:KO). 240,800 were reported by Fukoku Mutual Life. Utd Bank stated it has 24,795 shares or 0.47% of all its holdings.

Among 8 analysts covering Immunogen (NASDAQ:IMGN), 5 have Buy rating, 1 Sell and 2 Hold. Therefore 63% are positive. Immunogen had 23 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Sunday, August 6. RBC Capital Markets downgraded the stock to “Sector Perform” rating in Friday, April 29 report. RBC Capital Markets maintained the stock with “Outperform” rating in Monday, July 27 report. Jefferies maintained the stock with “Buy” rating in Friday, September 8 report. The rating was maintained by Jefferies on Monday, June 26 with “Buy”. The rating was maintained by Canaccord Genuity with “Buy” on Wednesday, August 30. The stock of ImmunoGen, Inc. (NASDAQ:IMGN) has “Buy” rating given on Wednesday, November 25 by Jefferies. The rating was maintained by RBC Capital Markets on Monday, October 2 with “Buy”. Cowen & Co maintained the shares of IMGN in report on Tuesday, August 29 with “Hold” rating. The rating was maintained by RBC Capital Markets on Tuesday, August 29 with “Buy”.